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ABSTRACT 36 
Hyperthermia reduces the capacity to withstand a simulated hemorrhagic challenge, but volume 37 
loading preserves this capacity.  This study tested the hypotheses that acute volume expansion during 38 
hyperthermia increases cerebral perfusion and attenuates reductions in cerebral perfusion during a 39 
simulated hemorrhagic challenge induced by lower body negative pressure (LBNP).  Eight healthy 40 
young male subjects underwent a supine baseline period (pre-LBNP), followed by 15 and 30 mmHg 41 
LBNP while normothermic, hyperthermic (increased pulmonary artery blood temperature ~1.1°C), and 42 
following acute volume infusion while hyperthermic.  Primary dependent variables were: mean middle 43 
cerebral artery blood velocity (MCAvmean) - serving as an index of cerebral perfusion, mean arterial 44 
pressure (MAP), and cardiac output (thermodilution).  During baseline, hyperthermia reduced MCAvmean 45 
(P=0.001) by 12 ± 9% relative to normothermia.  Volume infusion while hyperthermic increased cardiac 46 
output by 2.8 ± 1.4 L/min (P<0.001), but did not alter MCAvmean (P=0.99) or MAP (P=0.39), when 47 
compared to hyperthermia alone.  Relative to hyperthermia, at 30 mmHg LBNP acute volume infusion 48 
attenuated reductions (P<0.001) in cardiac output (by 2.5 ± 0.9 L/min; P<0.001), MAP (by 5 ± 6 mmHg; 49 
P=0.004), and MCAvmean (by 12 ± 13%; P=0.002).  These data indicate that acute volume expansion 50 
does not reverse hyperthermia-induced reductions in cerebral perfusion pre-LBNP, but that it does 51 
attenuate reductions in cerebral perfusion during simulated hemorrhage in hyperthermic humans. 52 
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INTRODUCTION  71 
In humans, the ability to maintain arterial pressure, and ultimately cerebral perfusion, during an 72 
orthostatic (e.g., by standing up or upright tilt) or a simulated hemorrhagic challenge (e.g., by lower 73 
body negative pressure; LBNP (4)) is compromised during hyperthermia (17, 19, 30). This 74 
hyperthermia-induced impairment involves numerous mechanisms including, insufficient increases in 75 
peripheral resistance (8, 14, 25), decreases in ventricular filling pressures (10, 32) - which occur 76 
subsequent to reductions in the central blood volume (9, 10) - impaired arterial baroreflex control of 77 
blood pressure (5), and reductions in cerebral perfusion (2, 21, 30).   78 
Various countermeasures are effective in maintaining arterial pressure and cerebral perfusion 79 
during a simulated hemorrhagic challenge in heat stressed individuals, such as rapid skin cooling (31) 80 
and acute plasma volume expansion (17).  The mechanism(s) by which acute volume expansion 81 
preserves the capability to maintain cardiovascular integrity during hyperthermia remains unknown.  82 
Volume loading may attenuate the LBNP-induced reduction in stroke volume and cardiac output such 83 
that arterial pressure and therefore, presumably, cerebral perfusion is preserved (3, 10).  Alternatively, 84 
acute volume expansion in heat stressed individuals may, independent of changes in arterial pressure, 85 
augment cerebral perfusion secondary to an increase in cardiac output, and subsequent arterial 86 
baroreflex mediated changes in cerebral vascular tone (22, 23), as shown in normothermic individuals 87 
(24).  However, the effect of acute volume loading on cerebral perfusion in heat stressed individuals, 88 
either at rest or during a subsequent simulated hemorrhage, remains unknown.  Therefore, the purpose 89 
of this study was to test the hypotheses that acute plasma volume expansion while hyperthermic will: 1) 90 
reverse hyperthermia-induced reductions in cerebral perfusion, and 2) attenuate reductions in cerebral 91 
perfusion during a simulated hemorrhagic challenge (i.e., LBNP).  The results were considered to 92 
illuminate the mechanisms by which acute volume infusion preserves the capacity to withstand a 93 
subsequent hemorrhagic challenge during hyperthermia, which is of importance for the treatment of 94 
hyperthermic, hemorrhagic individuals. 95 
  96 
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METHODS 97 
Eight healthy male volunteers participated in this study.  The subject characteristics were (mean 98 
± SD) - Age: 29 ± 5 y; Height: 180 ± 5 cm; Weight: 75 ± 4 kg; Body surface area: 1.5 ± 0.1 m2.  All 99 
subjects were non-smokers, not taking medications and were free of any known cardiovascular, 100 
metabolic, or neurological diseases.  Each subject was fully informed of the experimental procedures 101 
and possible risks before giving informed written consent.  This protocol was approved by the Ethics 102 
Committee of Copenhagen (H-KF-090/04) and was registered with the Danish data protection agency 103 
and ClinicalTrials.gov under the national library of medicine (NCT00714766).  All procedures 104 
conformed to the standards set by the Declaration of Helsinki.  Subjects arrived at the laboratory 105 
euhydrated (having ingested ~1.8 L of fluid during the prior 24 h) and having refrained from strenuous 106 
exercise, alcohol and caffeine for a period of 24 h.  These data were collected concurrently with those 107 
presented in a published manuscript, which tested a unique research hypothesis (3). 108 
 109 
Instrumentation and measurements 110 
Mean skin temperature was measured from the weighted average of six thermocouples 111 
attached to the skin (27).  Body temperature was controlled via a water-perfused tube lined suit (Med-112 
Eng, Ottawa, ON, Canada), that covered the entire body except the head, hands, one forearm, and the 113 
feet.  Heart rate was continually recorded from a five lead electrocardiogram.  Mean arterial pressure 114 
(MAP) was measured via a catheter placed in the brachial artery of the non-dominant arm.  Pulmonary 115 
artery blood temperature was measured via a flow-directed pulmonary arterial catheter (93A-831H-116 
7.5F, Baxter Healthcare Corporation, Irvine, CA, USA) introduced through the basilica vein of the left 117 
arm and advanced to the pulmonary artery.  Central venous pressure (CVP) was measured via an 118 
alternate port on the pulmonary arterial catheter.  Vascular pressures were referenced to atmospheric 119 
pressure via uniflow pressure transducers (Baxter Healthcare Corporation) that were zeroed 5 cm 120 
below the sternal notch and connected to a pressure-monitoring system (Dialogue 2000, ICB-Danica, 121 
Copenhagen, Denmark).  All catheters were flushed with isotonic saline at 3 ml/h.  Arterial blood 122 
samples were analyzed for changes in arterial carbon dioxide tension (PaCO2), hemoglobin, and thus 123 
hematocrit (Radiometer ABL700, Brønshøj, Denmark) and corrected to pulmonary artery blood 124 
temperature.  Cardiac output was measured in triplicate via the thermodilution method (15).  Mean 125 
middle cerebral artery blood velocity (MCAvmean) served as an index of cerebral perfusion and was 126 
measured by adjusting a 2 MHz Doppler probe (Multidop X, DWL, Sipplingen, Germany) over the 127 
temporal window (1, 29).   128 
 129 
 130 
 131 
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Experimental protocol 132 
Following instrumentation, subjects rested quietly in the supine position while normothermic 133 
water (34°C) perfused the suit.  After normothermic baseline data collection, LBNP commenced at 15 134 
mmHg, which was immediately followed by 30 mmHg.  30 mmHg LBNP was the highest level applied 135 
as it was expected that all subjects could tolerate this LBNP during hyperthermia for a period sufficient 136 
to obtain the desired data prior to symptoms of syncope.  The duration of each LBNP stage for all 137 
thermal conditions was ~15 min, which was required to obtain the data reported in the companion 138 
paper (3).  Following normothermic LBNP, the subjects underwent whole-body passive heat stress by 139 
perfusing 46-48°C water through the suit.  This heat stress continued until pulmonary artery blood 140 
temperature increased ~1.0°C (typically after 30-45 min), after which the water temperature was slightly 141 
reduced to attenuate further increases in body temperature during the ensuing data collection periods.  142 
The subjects were not allowed to drink at any time during the experimental procedures.  Hyperthermic 143 
baseline data were then obtained, which was followed by 15 and 30 mmHg LBNP.  Following a brief 144 
recovery after the cessation of LBNP and while remaining heat stressed, 500 ml of ~38°C colloid 145 
solution (HES 130/0.4, Voluven, Fresenius Kabi, Sweden) followed by warm saline was rapidly infused.  146 
The total infused volume was ~12 ml/kg and typically administered in less than 10 min.  Baseline data 147 
were collected after the completion of the infusion, which was then followed by 15 and 30 mmHg LBNP. 148 
 149 
Data analysis 150 
Thermal, hemodynamic, and pressure data were sampled at 50 Hz via a data acquisition 151 
system (Biopac System, Santa Barbara, CA, USA).  Data were reduced into 60 s averages during the 152 
baseline periods and following 5 min of each stage of LBNP.  Stroke volume was calculated from 153 
cardiac output and heart rate, while systemic vascular resistance (SVR) was calculated as (MAP – 154 
CVP) divided by cardiac output.  An index of cerebral vascular resistance (CVR) was calculated as the 155 
quotient of MAP and MCAvmean.  Percentage changes in plasma volume, occurring as a result of the 156 
volume infusion, were estimated from changes in hematocrit and hemoglobin (12).  Data during LBNP 157 
are presented as absolute values and as a change (∆) from pre-LBNP baseline for each respective 158 
condition. 159 
 160 
Statistical analysis 161 
Data at baseline for normothermia, hyperthermia, hyperthermia + infusion were analyzed using 162 
one-way repeated measures analysis of variance (ANOVA) (hypothesis one), while data during LBNP 163 
during the hyperthermia and hyperthermia + infusion conditions were analyzed using a two-way 164 
repeated measures ANOVA (2 x 3; condition x LBNP) (hypothesis two).  Data during the normothermic 165 
condition were not included in the analysis for hypothesis two given that the inclusion of this data was 166 
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not necessary to test this hypothesis.  Where appropriate, post hoc, pair-wise, comparisons were made 167 
incorporating a Bonferroni adjustment.  Data were analyzed using SigmaPlot (v.12, Systat Software 168 
Inc., Chicago, IL, USA) with a priori statistical significance set at P≤0.05.  All data are reported as mean 169 
± SD.   170 
  171 
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RESULTS 172 
Normothermia, hyperthermia, and hyperthermia + volume infusion baselines (hypothesis one) 173 
Thermal and hemodynamic variables during normothermia, hyperthermia, and following the 174 
volume infusion baseline (pre-LBNP) periods are presented in Table 1.  Relative to normothermia, 175 
hyperthermia was characterized by ~1.1 and ~2.8°C increases (P<0.001) in pulmonary artery blood 176 
and mean skin temperatures, respectively, which were maintained (P=0.084) during the infusion.  The 177 
volume infusion increased plasma volume by 18 ± 5%, and augmented (P<0.001) cardiac output, but 178 
did not affect (P=0.999) MAP.  Notably, PaCO2 was well maintained (P=0.351) throughout these 179 
baseline periods.  MCAvmean and CVR at baseline are presented in Figure 1.  Relative to normothermia, 180 
MCAvmean was reduced (P=0.001) by 12 ± 9% during hyperthermia and was unaffected (P=0.394) by 181 
volume infusion.  CVR was similar (P=0.471) throughout all baseline periods. 182 
 183 
Lower body negative pressure (hypothesis two)   184 
Pulmonary artery temperature was ~0.2°C higher (P=0.006) throughout LBNP following the 185 
volume infusion (38.0 ± 0.3°C), relative to during hyperthermia alone (37.8 ± 0.4°C).  MCAvmean and 186 
CVR during LBNP are presented in Figure 2.  CVR remained constant (P=0.281) as LBNP progressed, 187 
while MCAvmean decreased (P<0.001) in both conditions.  However, relative to hyperthermia, volume 188 
infusion attenuated the reduction in MCAvmean during 15 (P=0.049) and 30 (P=0.002) mmHg LBNP.  189 
Hemodynamic variables during LBNP are presented in Figure 3.  Cardiac output, stroke volume, MAP, 190 
and CVP all decreased (P<0.001) as LBNP progressed, while SVR increased (P<0.001).  At both 191 
stages of LBNP, volume infusion augmented (P≤0.001) cardiac output and stroke volume, while it 192 
attenuated (P=0.004) the reduction in MAP at 30 mmHg LBNP.  During LBNP, PaCO2 was similar 193 
(P=0.559) between hyperthermia (33 ± 5 mmHg) and volume infusion (35 ± 5 mmHg) conditions. 194 
 195 
  196 
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DISCUSSION 197 
 The purpose of this study was to test the hypotheses that acute plasma volume expansion 198 
during hyperthermia elevates cerebral perfusion at rest and attenuates reductions in cerebral perfusion 199 
during a subsequent simulated hemorrhagic challenge.  The novel findings of this study are that acute 200 
volume expansion: a) does not reverse hyperthermia-induced reductions in cerebral perfusion at rest, 201 
but that b) it attenuates reductions in cerebral perfusion during a subsequent simulated hemorrhage 202 
while hyperthermic.  That is, an increase in pulmonary artery blood temperature of ~1.1°C (Table 1) 203 
reduced MCAvmean by ~12% (Fig. 1), but acute volume infusion sufficient to increase cardiac output by 204 
almost 3 L/min (Table 1) did not restore MCAvmean towards normothermic levels (Fig. 1).  However, 205 
acute volume infusion during hyperthermia did attenuate LBNP-induced reductions in MCAvmean (Fig. 206 
2).  This was likely a function of the volume infusion’s augmentation of cardiac output and stroke 207 
volume prior to LBNP (Fig. 3), which better maintained MAP at a given level of LBNP (Fig. 3), thereby 208 
forestalling LBNP-induced reductions in MCAvmean (Fig. 2).  These data indicate that cardiac output is 209 
not capable of directly (i.e., independent of arterial pressure) modulating cerebral blood flow during 210 
hyperthermia.  However, the data do support that the beneficial effects of acute volume loading prior to 211 
a hyperthermic simulated hemorrhage are, at least partially, mediated via the preservation of arterial 212 
pressure and by extension, the maintenance of cerebral perfusion.  213 
 214 
Acute volume expansion and cerebral perfusion during hyperthermia 215 
 During normothermia, experimentally-induced fluctuations in cardiac output directly modulate 216 
brain blood flow in humans (24).  Presumably, this effect is mediated via the arterial baroreflex and 217 
subsequent changes in cerebral vascular tone occurring secondary to changes in sympathetic nerve 218 
activity (22, 23).  Accordingly, we hypothesized that the same phenomenon would occur during 219 
hyperthermia, such that the augmentation of cardiac output would (at least partially) restore 220 
hyperthermia-induced reductions in cerebral perfusion.  However, this was not the case (Fig. 1).  There 221 
are two potential reasons for this observation.   222 
First, acute volume expansion during hyperthermia restores central blood volume to 223 
normothermic levels (9) and augments an already elevated skin blood flow (7).  Thus, increases in 224 
blood flow as a consequence of volume infusion in those vascular beds with a low vascular resistance 225 
(e.g., the cutaneous vasculature) appear likely, whereas blood flow in vascular beds with a higher 226 
vascular resistance (e.g., the cerebral vasculature) would remain constant.  As evidence for this 227 
hypothesis, in the present study systemic vascular resistance further decreased during volume infusion 228 
(Table 1), while MCAvmean and CVR were unchanged (Fig. 1). 229 
Second, the effect of increasing cardiac output on the cerebral vasculature during normothermia 230 
may be mediated by the arterial baroreflex and subsequent changes in sympathetic nerve activity (22, 231 
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23).  Hyperthermia impairs the responsiveness of some aspects of the baroreflex (5) and also shifts the 232 
baroreflex operating point (5, 11) in order to accommodate hyperthermia-induced hemodynamic 233 
changes (6).  Thus, the sensitivity of the cerebral vasculature to modify blood flow to a given change in 234 
cardiac output may be reduced during hyperthermia.  However, this remains speculative as there is no 235 
direct evidence in support of such an arrangement.  It is also notable that this hypothesis requires that 236 
the sympathetic nervous system innervate cerebral vessels and modify cerebral blood flow in humans, 237 
which remains debated (28).  238 
 239 
Acute volume expansion and cerebral perfusion during hyperthermic LBNP 240 
 The ability to withstand a hemorrhagic challenge is reduced during hyperthermia, while acute 241 
volume expansion reverses this intolerance (17).  The mechanisms underlying this observation are not 242 
currently known.  We hypothesized that, relative to hyperthermia alone, acute volume expansion during 243 
hyperthermia would attenuate reductions in cerebral perfusion at a given level of LBNP.  The present 244 
data support this hypothesis.  Specifically, following volume infusion, MCAvmean during LBNP was 245 
higher than during hyperthermia alone (Fig. 2).  These data indicate that during simulated hemorrhage 246 
cerebral perfusion is better maintained during hyperthermia following volume expansion.  From the 247 
testing of our first hypothesis, the mechanism for this observation is not via the direct influence of acute 248 
volume loading, and subsequent increases in cardiac output, on cerebral perfusion prior the simulated 249 
hemorrhagic challenge.  Rather, these data support the proposal (see: 3, 10) that volume expansion 250 
results in a higher cardiac output and stroke volume at a given level of LBNP (Fig. 3), which better 251 
maintains arterial pressure (Fig. 3) and in turn maintains cerebral perfusion as LBNP progressed (Fig. 252 
2).  Thus, these data suggest that the preservation of simulated hemorrhagic tolerance following 253 
volume infusion during hyperthermia is, at least partially, mediated via attenuations in LBNP-induced 254 
reductions in arterial pressure and cerebral perfusion. 255 
 256 
Methodological considerations 257 
 Given the invasive nature of this study, it was not feasible to randomize the three experimental 258 
conditions as this would have required three separate laboratory visits and thus, arterial and right heart 259 
catheterization on three occasions.  Accordingly, pulmonary artery blood temperature was slightly 260 
higher (~0.2°C) during LBNP with volume infusion relative to LBNP during hyperthermia alone.  Given 261 
these slight temperature differences and that cerebral perfusion progressively decreases as internal 262 
body temperature increases - albeit at larger increments than 0.2°C (13) - these findings suggest that 263 
we likely underestimated the magnitude of the beneficial effect of acute volume expansion on changes 264 
in cerebral perfusion during LBNP.   265 
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Given that these data were collected concurrently with another study (3), coupled with the 266 
aforementioned challenges resulting in it not being feasible to perform the experimental sessions on 267 
three separate days, in the present study we did not measure LBNP tolerance.  Thus, these data have 268 
been carefully interpreted and the conclusions drawn only pertain to situations involving the 269 
administered levels of LBNP.  Therefore, cerebral vascular responses during hyperthermia following 270 
acute volume expansion at the point of LBNP intolerance remain unknown.  Nevertheless, the 271 
presented data provide insights into possible mechanisms underlying the beneficial effects of acute 272 
volume expansion on LBNP tolerance during hyperthermia.   273 
It is also worth nothing that in the present study subjects were exposed to moderate levels of 274 
LBNP three times within a relatively short time period (~90 min).  It remains unknown whether there are 275 
any physiological effects of repeated moderate LBNP over this period, and if so whether those effects 276 
would be sufficient to influence the profound changes observed during heat stress and heat stress plus 277 
volume infusion.  That said, some changes do occur given that adaptation to daily LBNP exposures has 278 
been observed in as little as five consecutive days (18).  Whether this influenced the conclusions drawn 279 
presently remains uncertain. 280 
We utilized transcranial Doppler to quantify MCAvmean, which served as an index of cerebral 281 
perfusion given that this artery supplies ~80% of the blood flow received by each cerebral hemisphere 282 
(20).  However, it must be acknowledged that if the diameter of the insonated artery changes, then 283 
changes in blood velocity does not always reflect proportional changes in blood flow.  Yet, the diameter 284 
of the middle cerebral artery is unaffected by moderate carbon dioxide and blood pressure 285 
perturbations (16, 26).  Even still, the effect of hyperthermia on middle cerebral artery diameter remains 286 
uncertain. 287 
 288 
Conclusions 289 
The present study demonstrates that acute volume expansion does not reverse hyperthermia-290 
induced reductions in cerebral perfusion at rest, but that it does attenuate the reduction in cerebral 291 
perfusion during a subsequent simulated hemorrhage while hyperthermic.  Thus, cardiac output does 292 
not appear to directly (i.e., independent of arterial pressure) modulate cerebral blood flow during 293 
hyperthermia.  However, acute volume loading prior to a simulated hemorrhagic event while 294 
hyperthermic attenuates the LBNP-induced reductions in arterial pressure and, thereby better maintains 295 
cerebral perfusion.   296 
 297 
Perspectives    298 
Testing of these hypotheses has furthered the understanding of the mechanisms by which acute 299 
volume infusion preserves the capacity to withstand a subsequent hemorrhagic challenge during 300 
11 
 
hyperthermia.  The findings presented have implications for individuals at risk of a hemorrhagic injury 301 
under heat stress conditions (e.g., soldiers, firefighters, miners, etc.).  The data suggest that plasma 302 
volume loading in a hyperthermic individual prior to a hemorrhagic injury will assist in the maintenance 303 
of cerebral perfusion through stabilizing arterial pressure, as opposed to a direct effect of an increase in 304 
cardiac output, independent of arterial pressure, as has been found in normothermic individuals (24).  305 
 306 
  307 
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 401 
FIGURE LEGENDS 402 
 403 
Figure 1: Indices of cerebral perfusion and cerebral vascular resistance during Normothermia, 404 
Hyperthermia, and during hyperthermia following acute volume infusion (Hyperthermia + Infusion) 405 
(mean ± SD).  MCAvmean, mean middle cerebral artery blood velocity; CVR, cerebral vascular 406 
resistance; *, indicates significantly different from Normothermia (P≤0.03). 407 
 408 
Figure 2: Indices of cerebral perfusion and cerebral vascular resistance at baseline and during 15 and 409 
30 mmHg lower body negative pressure (LBNP) during Hyperthermia and hyperthermia following an 410 
acute volume infusion (Hyperthermia + Infusion) (mean ± SD).  MCAvmean, mean middle cerebral artery 411 
blood velocity; CVR, cerebral vascular resistance; ∆, indicates change from pre-LBNP baseline for each 412 
condition; †, indicates significantly different from Hyperthermia (P<0.05). 413 
 414 
Figure 3: Hemodynamic variables at baseline and during 15 and 30 mmHg lower body negative 415 
pressure (LBNP) during Hyperthermia and hyperthermia following an acute volume infusion 416 
(Hyperthermia + Infusion) (mean ± SD).  MAP, mean arterial pressure; CVP: central venous pressure; 417 
SVR, systemic vascular resistance; ∆, indicates change from pre-LBNP baseline for each condition; †, 418 
indicates significantly different from Hyperthermia (P≤0.011). 419 
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